'In the beginning, only about 25-35% of CAR-T cell recipients with chronic lymphocytic leukaemia experienced a complete remission of their cancer, says Porter.'

'In the beginning, only about 25-35% of CAR-T cell recipients with chronic lymphocytic leukaemia experienced a complete remission of their cancer, says Porter.' I'm not very familiar with pharma success rates, but isn't complete remission for 30% of virtually dead patients already an incredibly good result?